
[BIO USA 2025] SK biopharmaceuticals CEO highlights physician engagement, epilepsy sales in US
BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- SK biopharmaceuticals CEO Lee Dong-hoon highlighted the company’s evolving U.S. sales strategy and physician engagement plans during a luncheon media roundtable held Thursday on …